Online Registration
Operating Organization
Scientific Program
Stream 1: Opening Ceremony and Keynote Forum
|
Opening Ceremony Time: 09:00-09:15, Sept. 25, 2021 |
|
Plenary Forum Time: 09:15-12:00, Sept. 25, 2021 |
|
|
Moderator |
TBD |
|
Time |
Speeches and Speakers |
|
09:15-09:20 |
Moderator’s Introduction |
|
09:20-09:40 |
Title: Global Drug Development Strategy in there Era of ICH Dr. Dan Zhang, Board Director, Co-Founder, CSO, ClinChoice Inc, China (Foreign Member of Russian Academy of Engineering) |
|
09:40-10:00 |
Title: R&D of Broad-spectral Antivirals Dr. Shibo Jiang, Director, Institute of Medical Microbiology, Fudan University, China |
|
10:00-10:20 |
Title: Application of Nanotechnology in Drug Delivery Dr. Daxiang Cui, Professor, Shanghai Jiao Tong University, China |
|
10:20-10:40 |
Title: Drug Research Based on Protein-protein Interaction Dr. Qidong You, Professor & Dean, School of Pharmacy, China Pharmaceutical University, China |
| 10:20-10:40 |
Title: The Application of Prodrug Technology in the Discovery of New Drugs with Enhancement Dr. Qun (Max) Dang, President, Genuine Biotech, China |
| 10:40-11:00 |
Title: Cell Therapy for Kras-driven Cancer Dr. Yi Jin, CSO, Shanghai Genechem Co.,Ltd., China |
| 11:00-11:20 |
Sponsor Title: TBD Dr. Yongcong Tan, Senior Director, Sanyou Biopharmaceuticals Co., Ltd., China |
|
11:25-12:00 |
High-level dialogue Chair: Dr. Xinhua Zhou, CEO, Genor Biopharma Co. Ltd, China Dr. Lianshan Zhang, Senior Vice President/President of Global R&D, Jiangsu Hengrui Medicine, China |
|
Keynote Forum of IDDST2021 Time: 13:30-17:15, Sept. 25, 2021 |
|
|
Moderator |
TBD |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Moderator’s Introduction |
|
13:35-14:00 |
Title: Exploitationof the Emerging Chemical Elements in Drug Discovery Dr. Yinsheng Zhang, Vice President of Pharmaceutical R&D, Jiangsu Key Laboratory of Targeted Antiviral Research, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, China |
|
14:00-14:25 |
Title: Structure-Based Drug Design, Common Issues and Recent Progress Dr. Guosheng Wu, Vice President of Computational Drug Discovery, Pharmaron, China |
|
14:25-14:50 |
Title: TBD Dr. Deepak Hegde, CTO, EOC Pharma, China |
|
14:50-15:15 |
Title: A Simple but Effective De-ADCC/ADCP Techonoly for Antibody Drug Development Dr. Le Sun, President, AbMax Biotechnology Co., LTD, China |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Speech Opportunity Available |
| 15:55-16:20 | Speech Opportunity Available |
| 16:20-16:45 | Speech Opportunity Available |
| 16:45-17:15 | High-level dialogue |
Stream 2: Parallel Sessions
|
Session 1: Decoding Mechanism of Diseases and Drug Discovery |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Title: TBD Dr. Sui Xiong Cai, SVP & CTO, IMPACT Therapeutics, Inc, China |
|
14:00-14:25 |
Title: TBD Dr. Shaojian Lin, School of Medicine, Tongji University, China |
|
14:25-14:50 |
Title: Fragment-Based Screening by NMR Demonstrates the Druggability of Non-Coding RNA of SARS CoV-2 |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
Session 2: Recent Advances in Pharmacology and Toxicology |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: TBD Dr. Guoping Zhong, Associate Professor, Sun Yat-sen University, China |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Title: TBD Dr. Xiaojie Wang, Wenzhou Medical University, China |
|
10:15-10:30 |
Coffee Break |
|
Session 3: Novel Technology for Drug Discovery |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Title: TBD Dr. Xinfang Li, President, MabPlex International Co.. Ltd., China |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Title: TBD Dr. Pradeep V. Mahajan, Chairman & Managing Director, StemRx Bioscience Solutions Pvt. Ltd., India |
|
14:50-15:15 |
Title: Sugar Glass Vaccine: Making the Live Vaccines Preserved at Room Temperature for Long Time Dr. Fang Lv, Associate Researcher, Institute of Veterinary Immunology & Engineering, National Research Center of Engineering and Technology for Veterinary Biologicals, Jiangsu Academy of Agricultural Sciences, China |
|
15:15-15:30 |
Coffee Break |
|
Session 4: Computer-aided Drug Discovery and Development |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 5: Medicinal Chemistry and Drug Discovery |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Title: TBD Dr. Runhui Liu, Professor, East China University of Science and Technology, China |
|
14:00-14:25 |
Title: TBD Dr. Lan He, Professor, National Institutes for Food and Drug Control, China |
|
14:25-14:50 |
Title: TBD Dr. Zongxiang Tang, Head of Department, Nanjing University of Chinese Medicine, China |
|
14:50-15:15 |
Title: TBD Dr. Xinwang Yang, Director of Department of Anatomy and Histology & Embryology, Director of Peptide Probes & Drug Candidates Lab, Kunming Medical University, China |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: Natural Products Derived FXR Antagonist: Another side to Mainstay FXR Targeted Drug Discovery Dr. Weishuo Fang, Professor of Medicinal Chemistry, Institute of Materia Medica, Chinese Academy of Medical Sciences, China |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
Session 6: Drug Design and Synthesis |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: HFpEF, Re-examination and Evaluation of Preserved Ejection Fraction Heart Failure Dr. Michael Liebman, Managing Director & Co-Founder, IPQ Analytics, llc, USA |
|
09:25-09:50 |
Title: Advances in Multi-target Compounds Based on Cinnamic Acid Scaffold Dr. Josef Jampilek, Professor, Comenius University, Slovakia |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 7: Innovations in Drug Delivery System and Technology |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: Antibody Engineering for Immobilized Enzyme Bioconjugation |
|
14:25-14:50 |
Title: Antibody Engineering for Immobilized Enzyme Bioconjugation Dr. Henmei Ni, Professor, Department of Polymer Science, School of Chemistry and Chemical Engineering, Southeast University, China |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
Session 8: Bio-Hybrids and Novel Biosimilars |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 9: Nature Product & TCM Frontiers |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Title: Secondary Metabolites from Hainan Marine Invertebrates: Chemical diversity, Biological function and Druggability |
|
09:00-09:25 |
Title: Natural Variations and Genetic Interventions for Improvement of Wheat Agricultural Traits |
|
09:25-09:50 |
Title: TBD Dr. Zhongduo Yang, Professor, Lanzhou University of Technology, China |
|
09:50-10:15 |
Title: The Treatment of Thyroid Cancer with Ursolic Acid and Its Derivatives Dr. Fan Yuan, Professor, School of Chinese Materia Medica, Yunnan University of Traditional Chinese Medicine, China |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Title: Hypolipidemic and Hypoglycemic Effects of Corn Silk Polysaccharides and the Antioxidant Activity in H2O2 Induced Oxidative Damage Dr. Haixia Chen, Professor, School of Pharmaceutical Science and Technology, Tianjin University, China |
|
11:20-11:45 |
Title: Cultivars Ribonucleoprotein Bodies in Epidermal Cells of Caragana Arborescens L |
|
11:45-12:10 |
Title: The Essence of NAC Gene Family to the Cultivation of Drought-Resistant Soybean (Glycine Max L. Merr.) Cultivars |
| Session 10: Pharmaceutical Manufacturing and Integrative Services Time: Morning, Sept. 26, 2021 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: TBD |
|
14:25-14:50 |
Title: Regulatory Strategy of Compliance Management in New Era of Drug regulatory Science |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
| Session 11: Anticancer Drugs and Cancer Therapies Time: Morning, Sept. 26, 2021 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: Suppression of Cancer by Inhition of NF-kappa B in Peritoneal Cells Dr. Kazuo Umezawa, Professor, Aichi Medical University, Japan |
|
09:25-09:50 |
Title: Natural Products and Cancer Resistance Dr. Xiangxuan Zhao, Department of Radiology, Shengjing Hospital of China Medical University, China |
|
09:50-10:15 |
Title: TBD Dr. Jinbing Xie, Department of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing University, China |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Title: Boosting Cancer Nanomedicine with Hyperbaric Oxygen Therapy Dr. Zifu Li, Professor, Huazhong University of Science and Technology, China |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
| Session 12: Drugs and Therapies for CNS and Neurodegenerative Disorders Time: Afternoon, Sept. 26, 2021 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
| Session 13: Inflammation, Autoimmunity and Immune Diseases Drugs and Therapies Time: Afternoon, Sept. 26, 2021 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
| Session 14: Cardiovascular & Metabolic Diseases Drugs and Therapies Time: Morning, Sept. 27, 2021 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Title: TBD |
|
09:50-10:15 |
Title: Minimally Modified Low-density Lipoprotein Upregulates the 5-HT1B Receptor in Mouse Mesenteric Arteries in vivo by Activating the JAK2/STAT3 Pathway Dr. Jie Li, Associate professor, University of South China, China |
|
10:15-10:30 |
Coffee Break |
| Session 15: Infectious Diseases and Infections Drugs and Therapies Time: Morning, Sept. 27, 2021 |
|
|
Chair |
Dr. Tony W Coleman, Professor, University Lyon, France |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Title: Treatment of the Inherited Liver Diseases by Hepatocyte Transplantation |
|
14:00-14:25 |
Title: Why are the selective anti-bacterial properties of silver nitrate still effective after 6000 years? |
|
14:25-14:50 |
Title: TBD Dr. Simon Raymond, Professor, Melbourne University, Australia |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
| Session 16: Orphan Diseases and Other Diseases Drugs and Therapies Time: Morning, Sept. 27, 2021 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
 |
©2003-2021 All rights reserved by BIT Congress Inc. Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629 |